(Q45029364)

8 December 2017

title

Restrictive reimbursement policies: bias implications for claims-based drug safety studies (English)

1 reference

8 December 2017

1 reference

1

Joshua J Gagne

1 reference

8 December 2017

publication date

1 October 2014

1 reference

8 December 2017

1 reference

8 December 2017

volume

37

1 reference

8 December 2017

issue

10

1 reference

8 December 2017

page(s)

771-776

1 reference

Primer: administrative health databases in observational studies of drug effects--advantages and disadvantages

8 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS40264-014-0220-5

Causation of bias: the episcope

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-014-0220-5

A review of uses of health care utilization databases for epidemiologic research on therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-014-0220-5

Exposure misclassification as a result of free sample drug utilization in automated claims databases and its effect on a pharmacoepidemiology study of selective COX-2 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-014-0220-5

Evaluating the introduction of a computerized prior-authorization system on the completeness of drug exposure data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-014-0220-5

Coverage and prior authorization of psychotropic drugs under Medicare Part D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-014-0220-5

Cardiovascular outcomes after a change in prescription policy for clopidogrel

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-014-0220-5

Are claims data accurate enough to identify patients for performance measures or quality improvement? The case of diabetes, heart disease, and depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-014-0220-5

Estimation using all available covariate information versus a fixed look-back window for dichotomous covariates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-014-0220-5

Decreased mortality associated with the use of metformin compared with sulfonylurea monotherapy in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-014-0220-5

Quantifying the Impact of Drug Exposure Misclassification due to Restrictive Drug Coverage in Administrative Databases: A Simulation Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-014-0220-5

Randomized trials or observational tribulations?

21 January 2018

1 reference

12 December 2020

Restrictive drug coverage policies can induce substantial drug exposure misclassification in pharmacoepidemiologic studies

1 reference

12 December 2020

Four-dollar generics--increased accessibility, impaired quality assurance

1 reference

12 December 2020

Impact of a prior authorization policy for montelukast on clinical outcomes for asthma and allergic rhinitis among children and adolescents in a state Medicaid program.

1 reference

12 December 2020

Dalfampridine prior authorization program: a cohort study

1 reference

12 December 2020

10.1007/S40264-014-0220-5

Identifiers

DOI

1 reference

Dimensions Publication ID

8 December 2017

1040939717

0 references

1 reference